Insights+ Exclusive: COVID-19 Healthcare News Monthly Updates – June 2020
Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected in Wuhan City, Hubei Province, China in Dec 2019. Life sciences companies are putting all of their efforts into finding a treatment or developing a vaccine for this disease. PharmaShots is keeping a track of all of the important updates in the Lifesciences sector, where we have covered news updates regarding collaborations, clinical trials, funding, and regulatory guidelines related to the COVID-19 from Jan to date.
No comments
Last posts
- Glenmark Pharma Cuts Price of Covid-19 Drug FabiFlu by 27% to Rs 75 per Tablet
- Roche provides update on Phase III study of Tecentriq in women with advanced stage ovarian cancer
- ALZUMAb ( Itolizumab) from Biocon receives the approval from the Drug Controller General of India (DCGI) for use in moderate to severe COVID-19 patients.
- A-706,7th Floor, Winsway Complex Building No .2,A-Wing Chsl, Off Police Ln, opp. Andheri Railway Station, Mumbai-400069.Maharashtra,India
- +91-22-26399054
- +91-99-87711567 Whatsapp
- +91-99-87711567 Viber
- +91-99-87711567 Mobile
- applepharma Skype
- applepharmaceuticals Wechat
- 2097734872 QQ
- Mon-Sun 7.00 - 23.00
- applepharmaceutical@gmail.com
- More details